| dc.contributor.author | Akinci, Baris | |
| dc.contributor.author | Oral, Elif Arioglu | |
| dc.contributor.author | Meral, Rasimcan | |
| dc.date.accessioned | 2021-03-05T17:11:34Z | |
| dc.date.available | 2021-03-05T17:11:34Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Akinci B., Meral R., Oral E. A. , "Update on Therapeutic Options in Lipodystrophy", CURRENT DIABETES REPORTS, cilt.18, 2018 | |
| dc.identifier.issn | 1534-4827 | |
| dc.identifier.other | av_c459b959-d5b2-4f97-acda-902a5cfda080 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/130231 | |
| dc.identifier.uri | https://doi.org/10.1007/s11892-018-1100-7 | |
| dc.description.abstract | Purpose of Review The purpose of this review is to summarize the therapeutic approach for lipodystrophy syndromes with conventional treatment options and metreleptin therapy in detail and to point out the current investigational treatments in development. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp | |
| dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
| dc.title | Update on Therapeutic Options in Lipodystrophy | |
| dc.type | Makale | |
| dc.relation.journal | CURRENT DIABETES REPORTS | |
| dc.contributor.department | University of Michigan System , , | |
| dc.identifier.volume | 18 | |
| dc.identifier.issue | 12 | |
| dc.contributor.firstauthorID | 2357335 | |
